Skip to main content

Advertisement

Log in

Factors Associated with Non-disclosure of HIV Status in a Cohort of Childbearing HIV-Positive Women in Ukraine

  • Original Paper
  • Published:
AIDS and Behavior Aims and scope Submit manuscript

Abstract

Ukraine has one of the largest populations of persons living with HIV in Europe. Data on 2019 HIV-positive married or cohabiting women enrolled in a postnatal cohort from 2007 to 2012 were analysed to investigate prevalence and factors associated with self-reported non-disclosure of HIV status. Median age at enrolment was 27.5 years, with two-thirds diagnosed during their most recent pregnancy. Almost all had received antenatal antiretroviral therapy and 24 % were taking it currently. One-tenth (n = 198) had not disclosed their HIV status to their partner and 1 in 20 (n = 93) had disclosed to no-one. Factors associated with non-disclosure were: unmarried status (AOR 2.99 (95 % CI 1.51–5.92), younger age at leaving full-time education (AOR 0.41 (95 % CI 0.19–0.88) for ≥19 years vs ≤16 years) and lack of knowledge of partner’s HIV status (AOR 2.01 (95 % CI 1.09–3.66). Further work is needed to support disclosure in some groups and to explore relationships between disclosure and psychological factors in this setting, including depression, lack of support and perception of stigma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Joint United Nations Programme on HIV/AIDS (UNAIDS). Global report: UNAIDS report on the global AIDS epidemic 2013. Available from: http://www.unaids.org/sites/default/files/en/media/unaids/contentassets/documents/epidemiology/2013/gr2013/UNAIDS_Global_Report_2013_en.pdf.

  2. Mazhnaya A, Andreeva TI, Samuels S, DeHovitz J, Salyuk T, McNutt LA. The potential for bridging: HIV status awareness and risky sexual behaviour of injection drug users who have non-injecting permanent partners in Ukraine. J Int AIDS Soc. 2014;17:18825.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Booth RE, Lehman WE, Dvoryak S, Brewster JT, Sinitsyna L. Interventions with injection drug users in Ukraine. Addiction. 2009;104(11):1864–73.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Booth RE, Lehman WE, Kwiatkowski CF, Brewster JT, Sinitsyna L, Dvoryak S. Stimulant injectors in Ukraine: the next wave of the epidemic? AIDS Behav. 2008;12(4):652–61.

    Article  PubMed  Google Scholar 

  5. Corsi KF, Dvoryak S, Garver-Apgar C, Davis JM, Brewster JT, Lisovska O, et al. Gender differences between predictors of HIV status among PWID in Ukraine. Drug Alcohol Depend. 2014;138:103–8.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  6. Spicer N, Bogdan D, Brugha R, Harmer A, Murzalieva G, Semigina T. ‘It’s risky to walk in the city with syringes’: understanding access to HIV/AIDS services for injecting drug users in the former Soviet Union countries of Ukraine and Kyrgyzstan. Glob Health. 2011;7:22.

    Article  Google Scholar 

  7. Dvoriak S, Karachevsky A, Chhatre S, Booth R, Metzger D, Schumacher J, et al. Methadone maintenance for HIV positive and HIV negative patients in Kyiv: acceptability and treatment response. Drug Alcohol Depend. 2014;137:62–7.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  8. Bailey H, Townsend CL, Semenenko I, Malyuta R, Cortina-Borja M, Thorne C. Impact of expanded access to combination antiretroviral therapy in pregnancy: results from a cohort study in Ukraine. Bull World Health Organ. 2013;91(7):491–500.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Thorne C, Semenenko I, Pilipenko T, Malyuta R. Progress in prevention of mother-to-child transmission of HIV infection in Ukraine: results from a birth cohort study. BMC Infect Dis. 2009;9:40.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Malyuta R, Newell ML, Ostergren M, Thorne C, Zhilka N. Prevention of mother-to-child transmission of HIV infection: Ukraine experience to date. Eur J Public Health. 2006;16(2):123–7.

    Article  PubMed  Google Scholar 

  11. Grau LE, White E, Niccolai LM, Toussova OV, Verevochkin SV, Kozlov AP, et al. HIV disclosure, condom use, and awareness of HIV infection among HIV-positive, heterosexual drug injectors in St. Petersburg, Russian Federation. AIDS Behav. 2011;15(1):45–57.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Mellins CA, Havens JF, McCaskill EO, Leu CS, Brudney K, Chesney MA. Mental health, substance use and disclosure are significantly associated with the medical treatment adherence of HIV-infected mothers. Psychol Health Med. 2002;7(4):451–60.

    Article  Google Scholar 

  13. Mellins CA, Kang E, Leu CS, Havens JF, Chesney MA. Longitudinal study of mental health and psychosocial predictors of medical treatment adherence in mothers living with HIV disease. Aids Patient Care Studios. 2003;17(8):407–16.

    Article  Google Scholar 

  14. Jones SA, Sherman GG, Varga CA. Exploring socio-economic conditions and poor follow-up rates of HIV-exposed infants in Johannesburg, South Africa. Aids Care. 2005;17(4):466–70.

    Article  PubMed  CAS  Google Scholar 

  15. Hodgson I, Plummer ML, Konopka SN, Colvin CJ, Jonas E, Albertini J, et al. A systematic review of individual and contextual factors affecting ART initiation, adherence, and retention for HIV-infected pregnant and postpartum women. PloS One. 2014;9(11):e111421. doi:10.1371/journal.pone.0111421.

    Article  PubMed  PubMed Central  Google Scholar 

  16. World Health Organization. Guidance on couples HIV testing and counselling including antiretroviral therapy for treatment and prevention in serodiscordant couples: recommendations for a public health approach. Geneva: 2012 9789241501972.

  17. Demchenko IL, Sosidko TI, Kostyuchok MM, Belonosova NA, Salabai NV, Hvozdetska OM, et al. The people living with HIV Stigma Index. Kyiv; 2011.

  18. Medley A, Garcia-Moreno C, McGill S, Maman S. Rates, barriers and outcomes of HIV serostatus disclosure among women in developing countries: implications for prevention of mother-to-child transmission programmes. Bull World Health Organ. 2004;82(4):299–307.

    PubMed  PubMed Central  Google Scholar 

  19. Visser MJ, Neufeld S, de Villiers A, Makin JD, Forsyth BW. To tell or not to tell: South African women’s disclosure of HIV status during pregnancy. AIDS Care. 2008;20(9):1138–45.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Olagbuji BN, Ezeanochie MC, Agholor KN, Olagbuji YW, Ande AB, Okonofua FE. Spousal disclosure of HIV serostatus among women attending antenatal care in urban Nigeria. J Obstet Gynaecol. 2011;31(6):486–8.

    Article  PubMed  CAS  Google Scholar 

  21. Rujumba J, Neema S, Byamugisha R, Tylleskar T, Tumwine JK, Heggenhougen HK. “Telling my husband I have HIV is too heavy to come out of my mouth”: pregnant women’s disclosure experiences and support needs following antenatal HIV testing in eastern Uganda. J Int AIDS Soc. 2012;15(2):17429.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Tam M, Amzel A, Phelps BR. Disclosure of HIV serostatus among pregnant and postpartum women in sub-Saharan Africa: a systematic review. AIDS Care. 2015;27(4):436–50.

    Article  PubMed  Google Scholar 

  23. Demchenko IL, Artiukh O, Sosidko TI, Kostyuchok MM, Bielonosova N, Bryzhovata OS. The people living with HIV Stigma Index, Kyiv. 2014. http://www.stigmaindex.org. Accessed May 2015.

  24. Pinkham S, Malinowska-Sempruch K. Women, harm reduction and HIV. Reprod Health Matter. 2008;16(31):168–81.

    Article  Google Scholar 

  25. Burns K. Women, harm reduction, and HIV: key findings from Azerbaijan, Georgia, Kyrgyzstan, Russia, and Ukraine. New York, USA: Open Society Institute; 2009.

    Google Scholar 

  26. Saxton J, Malyuta R, Semenenko I, Pilipenko T, Tereshenko R, Kulakovskaya E, et al. Previous reproductive history and post-natal family planning among HIV-infected women in Ukraine. Hum Reprod. 2010;25(9):2366–73.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  27. Gourlay A, Birdthistle I, Mburu G, Iorpenda K, Wringe A. Barriers and facilitating factors to the uptake of antiretroviral drugs for prevention of mother-to-child transmission of HIV in sub-Saharan Africa: a systematic review. J Int AIDS Soc. 2013;16:18588.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Deribe K, Woldemichael K, Wondafrash M, Haile A, Amberbir A. Disclosure experience and associated factors among HIV positive men and women clinical service users in Southwest Ethiopia. BMC Public Health. 2008;8:81.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Kiriazova TK, Postnov OV, Perehinets IB, Neduzhko OO. Association of injecting drug use and late enrolment in HIV medical care in Odessa Region, Ukraine. HIV Med. 2013;14:38–41.

    Article  PubMed  Google Scholar 

  30. Kumarasamy N, Safren SA, Raminani SR, Pickard R, James R, Krishnan AKS, et al. Barriers and facilitators to antiretroviral medication adherence among patients with HIV in Chennai, India: a qualitative study. AIDS Patient Care Studios. 2005;19(8):526–37.

    Article  CAS  Google Scholar 

  31. WHO Department of Gender, Women and Health, WHO Cluster of Family and Community Health. Gender dimensions of HIV status disclosure to sexual partners: rates, barriers and outcomes for women. Geneva; 2004.

  32. Antelman G, Smith Fawzi MC, Kaaya S, Mbwambo J, Msamanga GI, Hunter DJ, et al. Predictors of HIV-1 serostatus disclosure: a prospective study among HIV-infected pregnant women in Dar es Salaam, Tanzania. AIDS. 2001;15(14):1865–74.

    Article  PubMed  CAS  Google Scholar 

  33. Jasseron C, Mandelbrot L, Dollfus C, Trocme N, Tubiana R, Teglas JP, et al. Non-disclosure of a pregnant woman’s HIV status to her partner is associated with non-optimal prevention of mother-to-child transmission. AIDS Behav. 2013;17(2):488–97.

    Article  PubMed  CAS  Google Scholar 

  34. Roxby AC, Matemo D, Drake AL, Kinuthia J, John-Stewart GC, Ongecha-Owuor F, et al. Pregnant women and disclosure to sexual partners after testing HIV-1-seropositive during antenatal care. AIDS Patient Care STDS. 2013;27(1):33–7.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Makin JD, Forsyth BW, Visser MJ, Sikkema KJ, Neufeld S, Jeffery B. Factors affecting disclosure in South African HIV-positive pregnant women. AIDS Patient Care STDS. 2008;22(11):907–16.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Calin T, Green J, Hetherton J, Brook G. Disclosure of HIV among black African men and women attending a London HIV clinic. AIDS Care. 2007;19(3):385–91.

    Article  PubMed  CAS  Google Scholar 

  37. Deribe K, Woldemichael K, Bernard N, Yakob B. Gender difference in HIV status disclosure among HIV positive service users. East Afr J Public Health. 2009;6(3):248–55.

    PubMed  Google Scholar 

  38. Ezegwui HU, Nwogu-Ikojo EE, Enwereji JO, Dim CC. HIV serostatus disclosure pattern among pregnant women in Enugu, Nigeria. J Biosoc Sci. 2009;41(6):789–98.

    Article  PubMed  CAS  Google Scholar 

  39. Stutterheim SE, Shiripinda I, Bos AE, Pryor JB, de Bruin M, Nellen JF, et al. HIV status disclosure among HIV-positive African and Afro-Caribbean people in the Netherlands. AIDS Care. 2011;23(2):195–205.

    Article  PubMed  Google Scholar 

  40. Bachanas P, Medley A, Pals S, Kidder D, Antelman G, Benech I, et al. Disclosure, knowledge of partner status, and condom use among HIV-positive patients attending clinical care in Tanzania, Kenya, and Namibia. AIDS Patient Care STDS. 2013;27(7):425–35.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Katz DA, Kiarie JN, John-Stewart GC, Richardson BA, John FN, Farquhar C. HIV testing men in the antenatal setting: understanding male non-disclosure. Int J STD AIDS. 2009;20(11):765–7.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  42. World Health Organization. Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations. Geneva; 2014.

  43. Wang L, Shan D, Chan S, Chen H, Ge Z, Ding G, et al. Disclosure of HIV-positive serostatus to sexual partners and associated factors in southern China. Int J STD AIDS. 2010;21(10):685–90.

    Article  PubMed  CAS  Google Scholar 

  44. Go VF, Quan VM, Voytek C, Celentano D, Nam LV. Intra-couple communication dynamics of HIV risk behavior among injecting drug users and their sexual partners in northern Vietnam. Drug Alcohol Depend. 2006;84(1):69–76.

    Article  PubMed  Google Scholar 

  45. Thorne C, Semenenko I, Malyuta R. Prevention of mother-to-child transmission of human immunodeficiency virus among pregnant women using injecting drugs in Ukraine, 2000-10. Addiction. 2012;107(1):118–28.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Vitek CR, Cakalo JI, Kruglov YV, Dumchev KV, Salyuk TO, Bozicevic I, et al. Slowing of the HIV epidemic in Ukraine: evidence from case reporting and key population surveys, 2005-2012. PloS One. 2014;9(9):e103657. doi:10.1371/journal.pone.0103657.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Bezabhe WM, Chalmers L, Bereznicki LR, Peterson GM, Bimirew MA, Kassie DM. Barriers and facilitators of adherence to antiretroviral drug therapy and retention in care among adult HIV-positive patients: a qualitative study from Ethiopia. PloS One. 2014;9(5):e97353. doi:10.1371/journal.pone.0097353.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Charurat M, Oyegunle M, Benjamin R, Habib A, Eze E, Ele P, et al. Patient retention and adherence to antiretrovirals in a large antiretroviral therapy program in Nigeria: a longitudinal analysis for risk factors. PloS One. 2010;5(5):e10584. doi:10.1371/journal.pone.0010584.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Bailey H, Thorne C, Malyuta R, Townsend CL, Semenenko I, Cortina-Borja M. Adherence to antiretroviral therapy during pregnancy and the first year postpartum among HIV-positive women in Ukraine. BMC Public Health. 2014;14:993.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Halperin J, Pathmanathan I, Richey LE. Disclosure of HIV status to social networks is strongly associated with increased retention among an urban cohort in New Orleans. AIDS Patient Care Studios. 2013;27(7):375–7.

    Article  Google Scholar 

  51. Bailey H, Thorne C, Semenenko I, Malyuta R, Tereschenko R, Adeyanova I, et al. Cervical screening within HIV care: findings from an HIV-positive cohort in Ukraine. PloS One. 2012;7(4):e34706. doi:10.1371/journal.pone.0034706.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  52. Wang B, Losina E, Stark R, Munro A, Walensky RP, Wilke M, et al. Loss to follow-up in a community clinic in South Africa—roles of gender, pregnancy and CD4 count. South Afr Med J. 2011;101(4):253–7.

    Google Scholar 

  53. French CE, Thorne C, Tariq S, Cortina-Borja M, Tookey PA. Immunologic status and virologic outcomes in repeat pregnancies to HIV-positive women not on antiretroviral therapy at conception: a case for lifelong antiretroviral therapy? AIDS. 2014;28(9):1369–72.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Tripathi V, King EJ, Finnerty E, Koshovska-Kostenko N, Skipalska H. Routine HIV counseling and testing during antenatal care in Ukraine: a qualitative study of the experiences and perspectives of pregnant women and antenatal care providers. AIDS Care. 2013;25(6):680–5.

    Article  PubMed  Google Scholar 

  55. Martsenkovsky I, Martyniuk V, Ougrin D. Delivering psychiatric services in primary care: is this the right way to go for Ukraine? Int Psychiatry. 2009;6(1):2–4.

    Google Scholar 

  56. Chaudoir SR, Fisher JD, Simoni JM. Understanding HIV disclosure: a review and application of the Disclosure Processes Model. Soc Sci Med. 2011;72:1618–29.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

The Ukraine Cohort of HIV-infected childbearing women Study Group consists of the following members: T. Pilipenko, A. Zayats, (Perinatal Prevention of AIDS Initiative, Odessa), Dr S. Posokhova (Regional Hospital, Odessa), Dr T. Kaleeva, Dr Y. Barishnikova, Dr S. Servetsky, Dr R. Teretsenko (Odessa Regional Centre for HIV/AIDS), Dr S. Solokha, Dr M. P. Grazhdanov, Dr E. Kulakovskaya (Donetsk Regional Centre for HIV/AIDS), Dr I. Raus, Dr O. V. Yurchenko, Dr I. Adeyanova (Kiev City Centre for HIV/AIDS), Dr Z Ruban, Dr O Govorun, Dr O Ostrovskaya, Dr I Kochergina, (Mykolaiv Regional Centre for HIV/AIDS), Dr L Kvasha, Dr G Kruglenko, Dr. N. Primak (Kriviy Rig City Center for HIV/AIDS). Claire Thorne held a Wellcome Trust Research Career Development Fellowship 2007–2012, which provided support for the Ukraine Cohort of HIV-infected Childbearing Women (grant number 081082). The ECS receives funding from the EU Seventh Framework Programme (FP7/2007–2013) under EuroCoord grant agreement n° 260694. Some of this work was undertaken at GOSH/UCL Institute of Child Health which received a proportion of funding from the UK Department of Health’s NIHR Biomedical Research Centres funding scheme. Funders were not involved in the study design, execution or analysis or the decision to submit the manuscript for publication, and the authors maintain full control of all primary data. The ECS has approval from the Great Ormond Street Hospital for Children NHS Trust/Institute of Child Health Research Ethics Committee.

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to Claire Thorne.

Supplementary EuroCoord Appendix

Supplementary EuroCoord Appendix

EuroCoord Executive Board: Fiona Burns, University College London, UK; Geneviève Chêne, University of Bordeaux, France; Dominique Costagliola (Scientific Coordinator), Institut National de la Santé et de la Recherche Médicale, France; Carlo Giaquinto, Fondazione PENTA, Italy; Jesper Grarup, Region Hovedstaden, Denmark; Ole Kirk, Region Hovedstaden, Denmark; Laurence Meyer, Institut National de la Santé et de la Recherche Médicale, France; Heather Bailey, University College London, UK; Alain Volny Anne, European AIDS Treatment Group, France; Alex Panteleev, St. Petersburg City AIDS Centre, Russian Federation; Andrew Phillips, University College London, UK, Kholoud Porter, University College London, UK; Claire Thorne, University College London, UK.

EuroCoord Council of Partners: Jean-Pierre Aboulker, Institut National de la Santé et de la Recherche Médicale, France; Jan Albert, Karolinska Institute, Sweden; Silvia Asandi, Romanian Angel Appeal Foundation, Romania; Geneviève Chêne, University of Bordeaux, France; Dominique Costagliola (chair), INSERM, France; Antonella d’Arminio Monforte, ICoNA Foundation, Italy; Stéphane De Wit, St. Pierre University Hospital, Belgium; Peter Reiss, Stichting HIV Monitoring, Netherlands; Julia Del Amo, Instituto de Salud Carlos III, Spain; José Gatell, Fundació Privada Clínic per a la Recerca Bíomèdica, Spain; Carlo Giaquinto, Fondazione PENTA, Italy; Osamah Hamouda, Robert Koch Institut, Germany; Igor Karpov, University of Minsk, Belarus; Bruno Ledergerber, University of Zurich, Switzerland; Jens Lundgren, Region Hovedstaden, Denmark; Ruslan Malyuta, Perinatal Prevention of AIDS Initiative, Ukraine; Claus Møller, Cadpeople A/S, Denmark; Kholoud Porter, University College London, United Kingdom; Maria Prins, Academic Medical Centre, Netherlands; Aza Rakhmanova, St. Petersburg City AIDS Centre, Russian Federation; Jürgen Rockstroh, University of Bonn, Germany; Magda Rosinska, National Institute of Public Health, National Institute of Hygiene, Poland; Manjinder Sandhu, Genome Research Limited; Claire Thorne, University College London, UK; Giota Touloumi, National and Kapodistrian University of Athens, Greece; Alain Volny Anne, European AIDS Treatment Group, France.

EuroCoord External Advisory Board: David Cooper, University of New South Wales, Australia; Nikos Dedes, Positive Voice, Greece; Kevin Fenton, Public Health England, USA; David Pizzuti, Gilead Sciences, USA; Marco Vitoria, World Health Organisation, Switzerland.

EuroCoord Secretariat: Silvia Faggion, Fondazione PENTA, Italy; Lorraine Fradette, University College London, UK; Richard Frost, University College London, UK; Andrea Cartier, University College London, UK; Dorthe Raben, Region Hovedstaden, Denmark; Christine Schwimmer, University of Bordeaux, France; Martin Scott, UCL European Research & Innovation Office, UK.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ahn, J.V., Bailey, H., Malyuta, R. et al. Factors Associated with Non-disclosure of HIV Status in a Cohort of Childbearing HIV-Positive Women in Ukraine. AIDS Behav 20, 174–183 (2016). https://doi.org/10.1007/s10461-015-1089-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10461-015-1089-8

Keywords

Navigation